Advisor Net Financial, Inc Bristol Myers Squibb CO Transaction History

Advisor Net Financial, Inc

$1.27 Billion
Q1 2025

A detailed history of Advisor Net Financial, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Advisor Net Financial, Inc holds 35,286 shares of BMY stock, worth $1.76 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

35,286

Previous 34,807 1.38%

Holding current value

$1.76 Million

Previous $1.97 Million 9.35%

% of portfolio

0.17%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	BUY	$53.9 - $63.11 $25,818 - $30,229	479 Added 1.38%	35,286 $2.15 Million
Q4 2024 Jan 13, 2025	SELL	$51.92 - $59.94 $73,466 - $84,815	-1,415 Reduced 3.91%	34,807 $1.97 Million
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $30,538 - $39,847	770 Added 2.17%	36,222 $1.87 Million
Q2 2024 Jul 16, 2024	BUY	$40.25 - $52.99 $83,438 - $109,848	2,073 Added 6.21%	35,452 $1.47 Million
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $198,541 - $225,107	4,138 Added 14.15%	33,379 $1.81 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $71,750 - $85,618	-1,480 Reduced 4.82%	29,241 $1.5 Million
Q3 2023 Oct 12, 2023	SELL	$57.89 - $64.73 $759,748 - $849,516	-13,124 Reduced 29.93%	30,721 $1.78 Million
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $112,129 - $124,502	1,760 Added 4.18%	43,845 $2.8 Million
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $11,827 - $13,415	180 Added 0.43%	42,085 $2.92 Million
Q4 2022 Jan 13, 2023	SELL	$68.48 - $81.09 $13,559 - $16,055	-198 Reduced 0.47%	41,905 $0
Q3 2022 Oct 04, 2022	BUY	$0.13 - $76.84 $315 - $186,721	2,430 Added 6.13%	42,103 $2.99 Million
Q2 2022 Jul 07, 2022	BUY	$72.62 - $79.98 $523,662 - $576,735	7,211 Added 22.21%	39,673 $3.06 Million
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $56,807 - $68,117	924 Added 2.93%	32,462 $2.37 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $15,874 - $18,505	-296 Reduced 0.93%	31,538 $1.97 Million
Q3 2021 Oct 15, 2021	SELL	$59.17 - $69.31 $2.21 Million - $2.59 Million	-37,318 Reduced 53.97%	31,834 $1.88 Million
Q2 2021 Jul 06, 2021	BUY	$61.91 - $67.42 $90,760 - $98,837	1,466 Added 2.17%	69,152 $4.62 Million
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $150,842 - $169,653	2,542 Added 3.9%	67,686 $4.27 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $31,814 - $36,051	551 Added 0.85%	65,144 $4.04 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $88,384 - $97,941	1,539 Added 2.44%	64,593 $3.89 Million
Q2 2020 Aug 26, 2020	SELL	$54.82 - $64.09 $158,320 - $185,091	-2,888 Reduced 4.38%	63,054 $3.71 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $178,547 - $259,470	-3,848 Reduced 5.51%	65,942 $3.68 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $73,421 - $95,771	1,492 Added 2.18%	69,790 $4.48 Million
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $11,847 - $14,046	277 Added 0.41%	68,298 $3.46 Million
Q2 2019 Jul 15, 2019	BUY	$44.62 - $49.34 $1.58 Million - $1.75 Million	35,441 Added 108.78%	68,021 $3.09 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $5,685 - $6,778	-126 Reduced 0.39%	32,580 $1.55 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $15,603 - $20,233	-320 Reduced 0.97%	32,706 $1.7 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $40,178 - $45,318	728 Added 2.25%	33,026 $2.05 Million
Q2 2018 Jul 27, 2018	BUY	$50.53 - $62.98 $32,440 - $40,433	642 Added 2.03%	32,298 $1.79 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $39,607 - $45,595	661 Added 2.13%	31,656 $2 Million
Q4 2017 Feb 27, 2018	BUY	$59.94 - $65.35 $1.86 Million - $2.03 Million	30,995	30,995 $1.9 Million

Others Institutions Holding BMY

# of Institutions

2,811

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $106B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Bristol Myers Squibb CO Transaction History